vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and Dime Community Bancshares, Inc. (DCOM). Click either name above to swap in a different company.

Dime Community Bancshares, Inc. is the larger business by last-quarter revenue ($123.8M vs $77.6M, roughly 1.6× Bioceres Crop Solutions Corp.). On growth, Dime Community Bancshares, Inc. posted the faster year-over-year revenue change (3040.1% vs -16.8%). Over the past eight quarters, Dime Community Bancshares, Inc.'s revenue compounded faster (22.9% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

The Dime Community Bank, originally known as the Dime Savings Bank of Williamsburgh, is a local, FDIC-insured bank headquartered in Hauppauge, New York. Founded in 1864, the bank was originally based in the Williamsburg neighborhood of Brooklyn, New York, and continues to operate with a strong market presence in this area. In 2017, Dime moved its headquarters to Brooklyn Heights. On Monday, February 1, 2021, Bridge Bancorp Inc. and Dime Community Bancshares successfully closed on a merger of ...

BIOX vs DCOM — Head-to-Head

Bigger by revenue
DCOM
DCOM
1.6× larger
DCOM
$123.8M
$77.6M
BIOX
Growing faster (revenue YoY)
DCOM
DCOM
+3056.9% gap
DCOM
3040.1%
-16.8%
BIOX
Faster 2-yr revenue CAGR
DCOM
DCOM
Annualised
DCOM
22.9%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BIOX
BIOX
DCOM
DCOM
Revenue
$77.6M
$123.8M
Net Profit
$-7.4M
Gross Margin
46.8%
Operating Margin
9.3%
38.6%
Net Margin
-9.6%
Revenue YoY
-16.8%
3040.1%
Net Profit YoY
-20.2%
EPS (diluted)
$-0.12
$0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
DCOM
DCOM
Q4 25
$123.8M
Q3 25
$77.6M
$115.6M
Q2 25
$109.7M
Q1 25
$60.6M
$103.8M
Q4 24
$98.8M
$3.9M
Q3 24
$93.3M
$87.6M
Q2 24
$87.3M
Q1 24
$84.0M
$82.0M
Net Profit
BIOX
BIOX
DCOM
DCOM
Q4 25
Q3 25
$-7.4M
$27.7M
Q2 25
$29.7M
Q1 25
$-1.6M
$21.5M
Q4 24
$605.2K
Q3 24
$-6.2M
$13.3M
Q2 24
$18.5M
Q1 24
$9.8M
$17.7M
Gross Margin
BIOX
BIOX
DCOM
DCOM
Q4 25
Q3 25
46.8%
Q2 25
Q1 25
39.4%
Q4 24
42.0%
Q3 24
40.2%
Q2 24
Q1 24
50.8%
Operating Margin
BIOX
BIOX
DCOM
DCOM
Q4 25
38.6%
Q3 25
9.3%
34.7%
Q2 25
36.6%
Q1 25
1.5%
27.6%
Q4 24
14.5%
-433.6%
Q3 24
2.5%
20.8%
Q2 24
29.8%
Q1 24
15.7%
29.6%
Net Margin
BIOX
BIOX
DCOM
DCOM
Q4 25
Q3 25
-9.6%
23.9%
Q2 25
27.1%
Q1 25
-2.6%
20.7%
Q4 24
0.6%
Q3 24
-6.6%
15.2%
Q2 24
21.2%
Q1 24
11.6%
21.6%
EPS (diluted)
BIOX
BIOX
DCOM
DCOM
Q4 25
$0.68
Q3 25
$-0.12
$0.59
Q2 25
$0.64
Q1 25
$-0.02
$0.45
Q4 24
$0.00
$-0.58
Q3 24
$-0.10
$0.29
Q2 24
$0.43
Q1 24
$0.14
$0.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
DCOM
DCOM
Cash + ST InvestmentsLiquidity on hand
$15.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$1.5B
Total Assets
$734.9M
$15.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
DCOM
DCOM
Q4 25
Q3 25
$15.5M
Q2 25
Q1 25
$38.5M
Q4 24
$29.2M
Q3 24
$32.3M
Q2 24
Q1 24
$16.4M
Stockholders' Equity
BIOX
BIOX
DCOM
DCOM
Q4 25
$1.5B
Q3 25
$288.3M
$1.5B
Q2 25
$1.4B
Q1 25
$345.0M
$1.4B
Q4 24
$346.3M
$1.4B
Q3 24
$346.0M
$1.3B
Q2 24
$1.3B
Q1 24
$348.5M
$1.2B
Total Assets
BIOX
BIOX
DCOM
DCOM
Q4 25
$15.3B
Q3 25
$734.9M
$14.5B
Q2 25
$14.2B
Q1 25
$798.2M
$14.1B
Q4 24
$835.2M
$14.4B
Q3 24
$827.3M
$13.7B
Q2 24
$13.5B
Q1 24
$836.1M
$13.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
DCOM
DCOM
Operating Cash FlowLast quarter
$14.4M
$186.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
DCOM
DCOM
Q4 25
$186.6M
Q3 25
$14.4M
$52.1M
Q2 25
$23.1M
Q1 25
$23.3M
$65.4M
Q4 24
$-5.4M
$99.1M
Q3 24
$5.2M
$-33.3M
Q2 24
$12.6M
Q1 24
$-17.4M
$30.7M
Free Cash Flow
BIOX
BIOX
DCOM
DCOM
Q4 25
Q3 25
$51.2M
Q2 25
$20.4M
Q1 25
Q4 24
Q3 24
$-34.1M
Q2 24
$9.2M
Q1 24
FCF Margin
BIOX
BIOX
DCOM
DCOM
Q4 25
Q3 25
44.3%
Q2 25
18.6%
Q1 25
Q4 24
Q3 24
-38.9%
Q2 24
10.5%
Q1 24
Capex Intensity
BIOX
BIOX
DCOM
DCOM
Q4 25
Q3 25
0.7%
Q2 25
2.4%
Q1 25
Q4 24
Q3 24
0.9%
Q2 24
3.9%
Q1 24
Cash Conversion
BIOX
BIOX
DCOM
DCOM
Q4 25
Q3 25
1.88×
Q2 25
0.78×
Q1 25
3.05×
Q4 24
-8.85×
Q3 24
-2.50×
Q2 24
0.68×
Q1 24
-1.78×
1.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons